What did UBS change in the CPAY analyst rating on Feb 10, 2026?

UBS maintained a Neutral rating on **CPAY** on Feb 10, 2026 and raised the price target to **$380** from **$315**, signaling valuation upside but continued caution.

Does the UBS action count as a CPAY upgrade or downgrade?

UBS did not upgrade or downgrade; it maintained Neutral. The firm raised the price target, which is constructive but not a formal upgrade in rating terms.

How should investors use the CPAY analyst rating and price target?

Treat the **CPAY analyst rating** and price target as one input among many. Use them with earnings, guidance, and Meyka’s grade to weigh risk and position size.

What is Meyka’s current view on CPAY?

Meyka AI rates **CPAY** with a grade of **A**, based on benchmark comparison, sector results, financial growth, key metrics, and analyst consensus. This is informational, not investment advice.

Analyst Ratings

UBS maintained Neutral on CPAY (Corpay, Inc.) Feb 10 2026, PT $380

ByDanny Kontos February 11, 2026

On Feb 10, 2026, UBS maintained a Neutral stance in the CPAY analyst rating while raising its price target to $380 from $315. The firm cited valuation upside but kept a cautious view on near-term execution. The move coincided with a measured stock move of 0.19% ($0.68) on the day and follows broad analyst attention on payments peers.